Drug Resistance Clinical Trials

11 recruitingLast updated: June 18, 2026

There are 11 actively recruiting drug resistance clinical trials across 17 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4. Top locations include Amiens, France, Ampang, Selangor, Malaysia, Argenteuil, France. Updated daily from ClinicalTrials.gov.


Drug Resistance Trials at a Glance

11 actively recruiting trials for drug resistance are listed on ClinicalTrialsFinder across 6 cities in 17 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Amiens, Ampang, and Argenteuil. Lead sponsors running drug resistance studies include Centre Hospitalier Régional d'Orléans, Centre Hospitalier de Saint-Denis, and Bugworks Research Inc..

Browse drug resistance trials by phase

Treatments under study

About Drug Resistance Clinical Trials

Looking for clinical trials for Drug Resistance? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Drug Resistance trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Drug Resistance clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Impacts of HIV Treatment Regimens on Archived Drug Resistance

HIV-1-infectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong420 enrolled1 locationNCT07643948
Recruiting

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Pseudomonas aeruginosaPrognosisPseudomonas Infections+3 more
Centre Hospitalier Régional d'Orléans600 enrolled48 locationsNCT06738771
Recruiting
Not Applicable

Cocreating Action to Improve Rationality in the Health System

Health-related Quality of LifeCommunity-Based Participatory ResearchHealth Literacy+7 more
Universidad Miguel Hernandez de Elche4,000 enrolled2 locationsNCT07237971
Recruiting
Phase 1

A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers

Infectious DiseasesAntimicrobial Drug Resistance
Bugworks Research Inc.48 enrolled1 locationNCT07029932
Recruiting
Phase 2

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors

Drug ResistanceMetastatic Solid CancersRadiotherapy+3 more
Chuangzhen Chen48 enrolled1 locationNCT07071103
Recruiting
Not Applicable

Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract

Antimicrobial Drug ResistanceDrug Resistance, Bacterial
Medical University of Warsaw360 enrolled1 locationNCT07094984
Recruiting

Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd

Metastatic Breast CancerHER2-positive Breast CancerHormone Receptor-Positive Breast Cancer+3 more
Hunan Cancer Hospital200 enrolled1 locationNCT07073755
Recruiting

Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients

Pneumonia, Ventilator-AssociatedIntensive Care UnitsAnti-Bacterial Agents+2 more
Centre Hospitalier de Saint-Denis300 enrolled1 locationNCT07052604
Recruiting
Phase 4

Optimising TREATment for Severe Gram-Negative Bacterial Infections

bloodstream infectionCarbapenem Resistant Bacterial InfectionMultidrug Resistance+2 more
National University of Singapore600 enrolled41 locationsNCT07004049
Recruiting

International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections

CirrhosisBacterial InfectionsMultidrug Resistance
Hospital Italiano de Buenos Aires1,000 enrolled1 locationNCT06634940
Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Antibiotic Resistant InfectionCarbapenem-Resistant Enterobacteriaceae InfectionVancomycin Resistant Enterococci Infection+5 more
The Methodist Hospital Research Institute1,000 enrolled2 locationsNCT06258551